Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IXJ vs. HRTS: which is better?

Bottom line

IXJ vs HRTS: the short answer

IXJ (iShares Global Healthcare ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 64% by weight.

But IXJ is far broader, holding 124 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.

IXJ is cheaper at 0.38% vs 0.75% — a difference of $37 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs +14.9% for IXJ.

Updated Nov 19, 2026

IXJ vs HRTS side by side

IXJHRTS
TypeETFETF
Fund familyiSharesInnovator
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.38%0.75%
Annual cost per $10k$38$75
10-yr cost on $10k (prospectus)$480$1,168
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+14.9%+23.6%
5-yr return (annualized)+6.4%—
10-yr return (annualized)+8.2%—
Best quarter+13.6%+15.8%
Worst quarter−11.8%−12.4%
Net assets (fund)$3.8B$51.9M
Number of holdings12445
Portfolio turnover2%4%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIXJHRTSDifference
2025+14.9%+23.6%−8.8%
2024+0.6%+3.6%−3.0%

Source: Fund prospectus bar charts

Holdings overlap

16 of IXJ's top 25 holdings also appear in HRTS's top 25.

Shared top holdings
HoldingIXJHRTS
Eli Lilly And Company10.93%11.52%
Johnson & Johnson7.04%3.59%
Abbvie Inc.5.12%2.40%
Unitedhealth Group Incorporated4.40%5.24%
Merck & Co., Inc.4.12%4.27%
Astrazeneca Plc3.76%4.00%
Novartis AG3.71%3.38%
Amgen Inc.2.54%1.91%
Thermo Fisher Scientific Incorporated2.42%3.97%
Abbott Laboratories2.05%2.61%
Gilead Sciences, Inc.2.04%3.43%
Novo Nordisk A/s1.99%5.24%
Vertex Pharmaceuticals Incorporated1.64%2.93%
Danaher Corporation1.56%2.66%
Bristol-myers Squibb Company1.53%2.09%

Source: SEC Form N-PORT

IXJ top 10

  1. Eli Lilly And Company — 10.93%
  2. Johnson & Johnson — 7.04%
  3. Abbvie Inc. — 5.12%
  4. Unitedhealth Group Incorporated — 4.40%
  5. Merck & Co., Inc. — 4.12%
  6. Astrazeneca Plc — 3.76%
  7. Roche Holding AG — 3.75%
  8. Novartis AG — 3.71%
  9. Amgen Inc. — 2.54%
  10. Thermo Fisher Scientific Incorporated — 2.42%

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

FAQ

What is the difference between IXJ and HRTS?
IXJ (iShares Global Healthcare ETF) and HRTS (Tema Heart & Health ETF) share a meaningful slice of their top holdings — about 64% by weight. But IXJ is far broader, holding 124 positions to 45 for HRTS, so beyond the top names it adds exposure HRTS doesn't have.
Which is cheaper, IXJ or HRTS?
IXJ has the lower expense ratio (0.38%).
Should I own both IXJ and HRTS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.